标题
Developing therapeutic vaccines against Alzheimer’s disease
作者
关键词
-
出版物
Expert Review of Vaccines
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2015-11-18
DOI
10.1586/14760584.2016.1121815
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
- (2015) Lauren Walker et al. ACTA NEUROPATHOLOGICA
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
- (2015) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- 2015 Alzheimer's disease facts and figures
- (2015) Alzheimers & Dementia
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Development of a high affinity Affibody-derived protein against amyloid β-peptide for future Alzheimer's disease therapy
- (2015) Erwin De Genst et al. Biotechnology Journal
- A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
- (2015) Hanna Lindberg et al. Biotechnology Journal
- Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk—Reply
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
- (2015) Zane Jaunmuktane et al. NATURE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Immunotherapeutic Approaches for Alzheimer’s Disease
- (2015) Thomas Wisniewski et al. NEURON
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms
- (2015) Christopher D. Morrone et al. Frontiers in Aging Neuroscience
- Development of a high affinity Affibody-derived protein against amyloid β-peptide for future Alzheimer's disease therapy
- (2015) Erwin De Genst et al. Biotechnology Journal
- A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
- (2015) Hanna Lindberg et al. Biotechnology Journal
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- ACTIVE Aβ IMMUNOTHERAPY CAD106 PHASE II DOSE-ADJUVANT FINDING STUDY: SAFETY AND CNS BIOMARKERS
- (2014) Ana Graf et al. Alzheimers & Dementia
- Immunotherapy for Alzheimer's disease
- (2014) Thomas Wisniewski et al. BIOCHEMICAL PHARMACOLOGY
- Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis
- (2014) May A Beydoun et al. BMC PUBLIC HEALTH
- Human CNS immune senescence and neurodegeneration
- (2014) Wolfgang J Streit et al. CURRENT OPINION IN IMMUNOLOGY
- Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
- (2014) Allal Boutajangout et al. GERONTOLOGY
- ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
- (2014) Takahisa Kanekiyo et al. NEURON
- Alzheimer’s Disease Genetics: From the Bench to the Clinic
- (2014) Celeste M. Karch et al. NEURON
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies
- (2014) Simon Dujardin et al. Acta Neuropathologica Communications
- Innate immunity stimulation via TLR9 in a non-human primate model of sporadic cerebral amyloid angiopathy
- (2013) Henrieta Scholtzova et al. Alzheimers & Dementia
- Pyroglutamate-3 Amyloid-β Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease–Like Transgenic Mouse Models
- (2013) Jeffrey L. Frost et al. AMERICAN JOURNAL OF PATHOLOGY
- TREM2 and the neuroimmunology of Alzheimer's disease
- (2013) Suzanne E. Hickman et al. BIOCHEMICAL PHARMACOLOGY
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
- (2013) Bin Zhang et al. CELL
- Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models
- (2013) Fernando Goñi et al. Journal of Neuroinflammation
- How Do Immune Cells Support and Shape the Brain in Health, Disease, and Aging?
- (2013) M. Schwartz et al. JOURNAL OF NEUROSCIENCE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Immunotherapy for Alzheimer’s disease: hoops and hurdles
- (2013) Cynthia A Lemere Molecular Neurodegeneration
- Immunotherapy for Alzheimer’s Disease
- (2013) Martin R. Farlow et al. NEUROLOGIC CLINICS
- Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment
- (2013) Antoine Lampron et al. NEURON
- Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies
- (2013) Florence Clavaguera et al. NEUROPHARMACOLOGY
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- Prions, prionoids and pathogenic proteins in Alzheimer disease
- (2013) Karen H. Ashe et al. Prion
- Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology
- (2013) J.-P. Michaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alzheimer Disease in 2020
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Therapeutic strategies for tau mediated neurodegeneration
- (2012) Y. Yoshiyama et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Active immunotherapy for Alzheimer's disease
- (2012) Thomas Wisniewski LANCET NEUROLOGY
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- Review: Experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology
- (2012) D. C. Lee et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Trans-Synaptic Spread of Tau Pathology In Vivo
- (2012) Li Liu et al. PLoS One
- Hyperphosphorylated tau in young and middle-aged subjects
- (2011) Adila Elobeid et al. ACTA NEUROPATHOLOGICA
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
- (2011) Mathias Jucker et al. ANNALS OF NEUROLOGY
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease
- (2011) Thomas S. Wingo ARCHIVES OF NEUROLOGY
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
- (2011) David T. Hickman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's Disease Brain-Derived Amyloid- -Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein
- (2011) A. E. Barry et al. JOURNAL OF NEUROSCIENCE
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
- (2010) Erika Chung et al. BMC NEUROSCIENCE
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
- (2010) Stephanie J. Soscia et al. PLoS One
- Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease
- (2010) Fernando Goñi et al. PLoS One
- Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding
- (2010) Wendy Noble et al. Prion
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
- (2009) Jörg Vollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunotherapy targeting abnormal protein conformation
- (2009) Thomas Wisniewski et al. Alzheimers & Dementia
- Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
- (2009) Rakez Kayed et al. CURRENT OPINION IN IMMUNOLOGY
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A -Stimulated Microglial Activation
- (2009) E. G. Reed-Geaghan et al. JOURNAL OF NEUROSCIENCE
- -Amyloid Monomers Are Neuroprotective
- (2009) M. L. Giuffrida et al. JOURNAL OF NEUROSCIENCE
- Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology
- (2009) H. Scholtzova et al. JOURNAL OF NEUROSCIENCE
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain
- (2008) Delphine Boche et al. BRAIN PATHOLOGY
- Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease
- (2008) Jing-Ji Jin et al. Journal of Neuroinflammation
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis
- (2008) Michael Pride et al. Neurodegenerative Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now